Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries

Paul Gehrtz, Shir Marom, Mike Bührmann, Julia Hardick, Silke Kleinbölting, Amit Shraga, Christian Dubiella, Ronen Gabizon, Jan N. Wiese, Matthias P. Müller, Galit Cohen, Ilana Babaev, Khriesto Shurrush, Liat Avram, Efrat Resnick, Haim Barr, Daniel Rauh, Nir London

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

High-throughput nanomole-scale synthesis allows for late-stage functionalization (LSF) of compounds in an efficient and economical manner. Here, we demonstrated that copper-catalyzed azide-alkyne cycloaddition could be used for the LSF of covalent kinase inhibitors at the nanoscale, enabling the synthesis of hundreds of compounds that did not require purification for biological assay screening, thus reducing experimental time drastically. We generated crude libraries of inhibitors for the kinase MKK7, derived from two different parental precursors, and analyzed them via the high-throughput In-Cell Western assay. Select inhibitors were resynthesized, validated via conventional biological and biochemical methods such as western blots and liquid chromatography-mass spectrometry (LC-MS) labeling, and successfully co-crystallized. Two of these compounds showed over 20-fold increased inhibitory activity compared to the parental compound. This study demonstrates that high-throughput LSF of covalent inhibitors at the nanomole-scale level can be an auspicious approach in improving the properties of lead chemical matter.

Original languageEnglish
Pages (from-to)10341-10356
Number of pages16
JournalJournal of Medicinal Chemistry
Volume65
Issue number15
DOIs
StatePublished - 11 Aug 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2022 American Chemical Society.

Funding

N.L. is the incumbent of the Alan and Laraine Fischer Career Development Chair. N.L. acknowledges funding from the Israel Science Foundation (grant no. 2462/19), the Israel Cancer Research Fund, and the Moross Integrated Cancer Center. N.L. is also supported by the Estate of Emile Mimran, Rising Tide Foundation, Honey and Dr. Barry Sherman Lab, Dr. Barry Sherman Institute for Medicinal Chemistry and Nelson P. Sirotsky.

FundersFunder number
Estate of Emile Mimran
Moross Integrated Cancer Center
Israel Cancer Research Fund
Israel Science Foundation2462/19
Rising Tide Foundation

    Fingerprint

    Dive into the research topics of 'Optimization of Covalent MKK7 Inhibitors via Crude Nanomole-Scale Libraries'. Together they form a unique fingerprint.

    Cite this